TSE:VHI Vitalhub (VHI) Stock Price, News & Analysis C$9.99 -0.08 (-0.79%) As of 10:40 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesBuy This Stock About Vitalhub Stock (TSE:VHI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Vitalhub alerts:Sign Up Key Stats Today's RangeC$9.99▼C$10.2050-Day RangeC$8.61▼C$11.9952-Week RangeC$5.80▼C$12.09Volume12,231 shsAverage Volume144,151 shsMarket CapitalizationC$540.38 millionP/E Ratio162.48Dividend YieldN/APrice TargetC$12.08Consensus RatingBuy Company OverviewVitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions. Vitalhub Corp. was founded in 2010 and is based in Toronto, Canada.Read More… Remove Ads Vitalhub Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks24th Percentile Overall ScoreVHI MarketRank™: Vitalhub scored higher than 24% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.5 / 5Analyst RatingBuy Consensus RatingVitalhub has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageVitalhub has only been the subject of 4 research reports in the past 90 days.Read more about Vitalhub's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Vitalhub is 162.48, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.53.Price to Earnings Ratio vs. SectorThe P/E ratio of Vitalhub is 162.48, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 23.44.Price to Earnings Growth RatioVitalhub has a PEG Ratio of 1.18. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioVitalhub has a P/B Ratio of 3.95. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for VHI. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldVitalhub does not currently pay a dividend.Dividend GrowthVitalhub does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for VHI. News and Social Media3.8 / 5News Sentiment0.92 News SentimentVitalhub has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 16 news articles for Vitalhub this week, compared to 1 article on an average week.Search Interest1 people have searched for VHI on MarketBeat in the last 30 days. MarketBeat Follows1 people have added Vitalhub to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Vitalhub insiders have not sold or bought any company stock.Percentage Held by Insiders18.57% of the stock of Vitalhub is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 32.40% of the stock of Vitalhub is held by institutions.Read more about Vitalhub's insider trading history. Receive VHI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vitalhub and its competitors with MarketBeat's FREE daily newsletter. Email Address VHI Stock News HeadlinesVitalhub Corp. (TSE:VHI) Receives Consensus Rating of "Buy" from BrokeragesApril 1 at 3:05 AM | americanbankingnews.comRaymond James Estimates Vitalhub's FY2024 Earnings (TSE:VHI)March 31 at 1:17 AM | americanbankingnews.comTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.April 2, 2025 | Priority Gold (Ad)Vitalhub (TSE:VHI) Given a C$13.50 Price Target by Raymond James AnalystsMarch 29, 2025 | americanbankingnews.comBeginner Investors: Now Is the Perfect Time to Put Money in the Market (Start With These 4 Stocks)March 21, 2025 | msn.comVitalHub Announces Q4 2024 Conference Call DateMarch 17, 2025 | finance.yahoo.com2 Brilliant Canadian Stocks to Buy Now and Hold for the Long TermMarch 15, 2025 | msn.comVitalhub Corp. (TSE:VHI) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?March 13, 2025 | uk.finance.yahoo.comSee More Headlines VHI Stock Analysis - Frequently Asked Questions How have VHI shares performed this year? Vitalhub's stock was trading at C$11.27 at the start of the year. Since then, VHI shares have decreased by 11.4% and is now trading at C$9.99. View the best growth stocks for 2025 here. How do I buy shares of Vitalhub? Shares of VHI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Vitalhub own? Based on aggregate information from My MarketBeat watchlists, some other companies that Vitalhub investors own include AST SpaceMobile (ASTS), Intel (INTC), Tempus AI (TEM), Recursion Pharmaceuticals (RXRX), Advanced Micro Devices (AMD), Broadcom (AVGO) and Genius Sports (GENI). Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Health Information Services Sub-IndustryChemicals Current SymbolTSE:VHI CIKN/A Webvitalhub.com Phone416-699-0123FaxN/AEmployees2,250Year FoundedN/APrice Target and Rating Average Stock Price TargetC$12.08 High Stock Price TargetC$14.00 Low Stock Price TargetC$8.00 Potential Upside/Downside+20.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)C$0.06 Trailing P/E Ratio163.78 Forward P/E Ratio43.85 P/E Growth1.18Net IncomeC$3.35 million Net Margins5.11% Pretax MarginN/A Return on Equity3.01% Return on Assets3.81% Debt Debt-to-Equity Ratio0.28 Current Ratio2.33 Quick RatioN/A Sales & Book Value Annual SalesC$65.49 million Price / Sales8.32 Cash FlowN/A Price / Cash FlowN/A Book ValueC$2.53 per share Price / Book3.98Miscellaneous Outstanding Shares54,092,368Free FloatN/AMarket CapC$544.71 million OptionableNot Optionable Beta1.26 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (TSE:VHI) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vitalhub Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vitalhub With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.